False positive serology of prepandemic chagasic samples with SARS-CoV-2 antigen

Juan D.H. Zuluaga, Juan C. Santos-Barbosa, Adriana Cuellar, Concepción J. Puerta, John M. Gonzalez

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Objective: To determine whether prepandemic sera from patients with Chagas disease recognise SARS-CoV-2 antigens. Materials and Methods: Forty sera from patients with Chagas disease were tested for the presence of IgG cross-reactivity against the nucleocapsid protein (NP) and spike (S) SARS-CoV-2 proteins by ELISA. Positive samples were tested again using a different ELISA and CLIA, both against NP. Results: None of the sera from patients with Chagas disease, previously confirmed as positive for the presence of anti-Trypanosoma cruzi antibodies reacted against the SARS-CoV-2 S protein, and six samples tested positive for the NP antigen (15%). The six positive samples were re-tested, five remained positive by ELISA and all were negative by CLIA. Conclusion: According to our data, false-positive results might be a concern in the detection of SARS-CoV-2 antibodies in patients with Chagas disease.

Original languageEnglish
Pages (from-to)1009-1012
Number of pages4
JournalTropical Medicine and International Health
Volume27
Issue number11
DOIs
StatePublished - Nov 2022

Keywords

  • COVID-19
  • Chagas disease
  • SARS-CoV-2
  • antibody cross-reactivity

Fingerprint

Dive into the research topics of 'False positive serology of prepandemic chagasic samples with SARS-CoV-2 antigen'. Together they form a unique fingerprint.

Cite this